Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | +2.42% | +8.97% | +32.36% |
Chart calendar Enanta Pharmaceuticals, Inc.
Upcoming events on Enanta Pharmaceuticals, Inc.
Past events on Enanta Pharmaceuticals, Inc.
2024-06-05 07:30 | Jefferies Global Healthcare Conference |
2024-05-14 10:00 | Citizens JMP Life Sciences Conference |
2024-05-06 16:30 | Q2 2024 Earnings Call |
2024-05-06 16:01 | Q2 2024 Earnings Release |
2024-04-27 06:00 | ESCMID Global Conference - Abstract Number: 02980 |
2024-03-13 10:40 | Leerink Partners Global Biopharma Conference - Fireside Chat |
2024-03-06 17:00 | Annual General Meeting |
2024-02-13 11:20 | Oppenheimer Healthcare Life Sciences Conference |
2024-02-07 16:30 | Q1 2024 Earnings Call |
2024-02-07 16:01 | Q1 2024 Earnings Release |
2024-01-10 12:45 | JPMorgan Healthcare Conference |
2023-11-29 07:55 | Evercore ISI HealthCONx Conference |
2023-11-20 16:30 | Q4 2023 Earnings Call |
2023-11-20 16:01 | Q4 2023 Earnings Release |
2023-10-20 08:00 | Investor Meeting - Key Opinion Leader |
2023-09-26 08:45 | Cantor Global Healthcare Conference - Fireside Chat |
2023-09-17 14:00 | ESWI Influenza Conference - Abstract No: 663 |
2023-09-13 13:25 | Baird Global Healthcare Conference - Fireside Chat |
2023-09-12 16:30 | H.C. Wainwright Global Investment Conference |
2023-09-07 14:15 | Wells Fargo Healthcare Conference - Fireside Chat |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 205 210 -2.21% | 122 125 -1.7% | 97,1 99,6 -2.53% | 86,2 89,1 -3.25% | 79,2 77,1 2.69% | 69,7 |
EBITDA Million USD | Released Forecast Spread | 59,2 46,0 28.74% | -18,4 -44,0 58.14% | -85,2 -104 18.03% | -93,9 -127 26.06% | -107 -148 27.96% | -117 |
EBIT Million USD | Released Forecast Spread | 36,7 42,0 -12.47% | -41,6 -43,9 5.24% | -110 -105 -4.82% | -124 -127 2.31% | -137 -151 9.31% | -125 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 45,6 51,2 -11.06% | -35,0 -37,3 6.11% | -108 -103 -4.22% | -122 -125 2.61% | -131 -151 13.01% | -132 |
Net income Million USD | Released Forecast Spread | 46,4 49,6 -6.58% | -36,2 -25,4 -42.24% | -79,0 -81,2 2.67% | -122 -123 1.36% | -134 -152 11.91% | -124 |
EPS USD | Released Forecast Spread | 2,21 2,35 -5.96% | -1,81 -1,29 -40.34% | -3,92 -3,99 1.66% | -5,91 -5,93 0.32% | -6,38 -7,21 11.47% | -5,80 |
Announcement Date | 21/11/19 | 23/11/20 | 22/11/21 | 21/11/22 | 20/11/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 18,7 20,7 -9.46% | 19,5 20,7 -6.05% | 20,3 23,1 -12.17% | 23,6 22,5 4.92% | 17,8 19,1 -6.63% | 18,9 16,7 12.88% | 18,9 17,5 8.2% | 18,0 21,9 -17.97% | 17,1 16,2 5.23% | 17,4 | 17,1 | 19,6 | 16,2 | 16,1 |
EBITDA Million USD | Released Forecast Spread | -24,0 | -32,1 -32,0 -0.45% | -27,0 | -25,0 | ||||||||||
EBIT Million USD | Released Forecast Spread | -33,8 -33,0 -2.59% | -32,5 -30,3 -7.48% | -27,0 -30,1 10.07% | -30,0 -34,0 11.63% | -39,5 -43,5 9.34% | -36,7 -55,0 33.31% | -31,0 -43,0 27.79% | -34,9 -23,6 -47.98% | -32,8 -29,2 -12.06% | -31,5 | -29,1 | -26,5 | -33,0 | -36,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,6 -33,3 -0.83% | -32,1 -29,9 -7.67% | -26,3 -29,8 11.63% | -29,0 -31,8 8.67% | -37,6 -42,1 10.63% | -34,8 -54,2 35.7% | -29,5 -46,6 36.69% | -34,0 -22,3 -52.88% | -31,5 -28,3 -11.2% | -34,0 | -33,6 | -30,5 | -31,5 | -34,5 |
Net income Million USD | Released Forecast Spread | -33,6 -30,2 -11.15% | -31,7 -28,6 -10.98% | -26,3 -28,8 8.58% | -29,0 -33,1 12.5% | -37,7 -39,6 4.98% | -39,1 -50,6 22.77% | -28,1 -44,7 37.13% | -33,4 -23,5 -42.05% | -31,2 -27,2 -14.76% | -32,2 | -32,2 | -26,5 | -31,5 | -34,5 |
EPS USD | Released Forecast Spread | -1,63 -1,43 -13.89% | -1,53 -1,37 -11.94% | -1,27 -1,34 4.99% | -1,39 -1,55 10.44% | -1,79 -1,92 6.84% | -1,86 -2,33 20% | -1,33 -2,15 38.04% | -1,58 -1,23 -28.93% | -1,47 -1,30 -13.2% | -1,47 | -1,34 | -1,28 | -1,50 | -1,58 |
Announcement Date | 09/05/22 | 08/08/22 | 21/11/22 | 07/02/23 | 08/05/23 | 07/08/23 | 20/11/23 | 07/02/24 | 06/05/24 | - | - | - | - | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Enanta Pharmaceuticals, Inc.
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENTA Stock
- Calendar Enanta Pharmaceuticals, Inc.